[P2] Poster Session (2) / Corporate Exhibits

Corporate ExhibitsVaccine Science

[C1-04] Strategies for Developing Safe and Effective mRNA-based Therapeutics and Vaccines

*Ken Miyajima¹, Yanwen Feng¹, Akiko Yanagiya¹, Rena Akahori², Miki Masai¹, Aoi Onuma¹, Hiroaki Murakami¹, Hayato Sato¹, Naoki Matsumoto¹, Jun Nihira¹, Tetsuo Yoshida¹, Kazuyuki Nakashima¹ (1. ARCALIS, Inc. (Japan), 2. Hitachi, Ltd. (Japan))

Keywords:

COVID-19 vaccine,mRNA,saRNA,CDMO

Password required to view

Log in

or